Wells Fargo’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.73K | Sell |
251
-6,397
| -96% | -$44.2K | ﹤0.01% | 5771 |
|
2025
Q1 | $35.3K | Buy |
6,648
+204
| +3% | +$1.08K | ﹤0.01% | 5053 |
|
2024
Q4 | $76K | Buy |
6,444
+2,195
| +52% | +$25.9K | ﹤0.01% | 4845 |
|
2024
Q3 | $87.7K | Sell |
4,249
-384
| -8% | -$7.92K | ﹤0.01% | 4697 |
|
2024
Q2 | $210K | Buy |
4,633
+3,552
| +329% | +$161K | ﹤0.01% | 4143 |
|
2024
Q1 | $42.4K | Buy |
1,081
+1,047
| +3,079% | +$41.1K | ﹤0.01% | 4945 |
|
2023
Q4 | $205 | Sell |
34
-581
| -94% | -$3.5K | ﹤0.01% | 6155 |
|
2023
Q3 | $4.15K | Buy |
615
+535
| +669% | +$3.61K | ﹤0.01% | 5609 |
|
2023
Q2 | $627 | Buy |
80
+1
| +1% | +$8 | ﹤0.01% | 6128 |
|
2023
Q1 | $575 | Sell |
79
-11,324
| -99% | -$82.4K | ﹤0.01% | 6195 |
|
2022
Q4 | $37.8K | Sell |
11,403
-160
| -1% | -$530 | ﹤0.01% | 4685 |
|
2022
Q3 | $57K | Sell |
11,563
-1
| -0% | -$5 | ﹤0.01% | 4591 |
|
2022
Q2 | $88K | Buy |
11,564
+2,637
| +30% | +$20.1K | ﹤0.01% | 4452 |
|
2022
Q1 | $142K | Buy |
8,927
+323
| +4% | +$5.14K | ﹤0.01% | 4843 |
|
2021
Q4 | $158K | Buy |
8,604
+235
| +3% | +$4.32K | ﹤0.01% | 5015 |
|
2021
Q3 | $257K | Buy |
8,369
+3,017
| +56% | +$92.6K | ﹤0.01% | 4715 |
|
2021
Q2 | $294K | Buy |
5,352
+1,313
| +33% | +$72.1K | ﹤0.01% | 4588 |
|
2021
Q1 | $238K | Buy |
4,039
+766
| +23% | +$45.1K | ﹤0.01% | 4765 |
|
2020
Q4 | $123K | Sell |
3,273
-3,192
| -49% | -$120K | ﹤0.01% | 5124 |
|
2020
Q3 | $349K | Buy |
6,465
+688
| +12% | +$37.1K | ﹤0.01% | 4484 |
|
2020
Q2 | $1.45M | Buy |
5,777
+1,481
| +34% | +$373K | ﹤0.01% | 3462 |
|
2020
Q1 | $675K | Buy |
4,296
+266
| +7% | +$41.8K | ﹤0.01% | 3700 |
|
2019
Q4 | $660K | Buy |
4,030
+57
| +1% | +$9.34K | ﹤0.01% | 4064 |
|
2019
Q3 | $580K | Buy |
3,973
+521
| +15% | +$76.1K | ﹤0.01% | 4162 |
|
2019
Q2 | $717K | Buy |
3,452
+228
| +7% | +$47.4K | ﹤0.01% | 4047 |
|
2019
Q1 | $672K | Buy |
3,224
+169
| +6% | +$35.2K | ﹤0.01% | 4114 |
|
2018
Q4 | $535K | Buy |
3,055
+219
| +8% | +$38.4K | ﹤0.01% | 4169 |
|
2018
Q3 | $643K | Sell |
2,836
-76
| -3% | -$17.2K | ﹤0.01% | 4183 |
|
2018
Q2 | $442K | Buy |
2,912
+221
| +8% | +$33.5K | ﹤0.01% | 4433 |
|
2018
Q1 | $493K | Buy |
2,691
+79
| +3% | +$14.5K | ﹤0.01% | 4289 |
|
2017
Q4 | $556K | Buy |
2,612
+849
| +48% | +$181K | ﹤0.01% | 4220 |
|
2017
Q3 | $379K | Buy |
1,763
+1,673
| +1,859% | +$360K | ﹤0.01% | 4389 |
|
2017
Q2 | $17K | Hold |
90
| – | – | ﹤0.01% | 5333 |
|
2017
Q1 | $22K | Buy |
90
+40
| +80% | +$9.78K | ﹤0.01% | 5336 |
|
2016
Q4 | $13K | Sell |
50
-67
| -57% | -$17.4K | ﹤0.01% | 5395 |
|
2016
Q3 | $24K | Buy |
+117
| New | +$24K | ﹤0.01% | 5261 |
|